FDA OKs Long-Acting Atypical Antipsychotic for Schizophrenia
Aristada (aripiprazole lauroxil) is injected every four-to-six weeks
Reduced-Dose Tacrolimus, Everolimus Cuts CMV Infection
Findings in de novo kidney recipients receiving no pharmacologic CMV prophylaxis
Prevention Bundle Can Cut Rate of Pediatric SSIs
Twenty-one percent reduction in SSI rate reported across network hospitals
Simvastatin, Vitamin D3 Combo Helps Prevent Migraines
Treatment effective for preventing headache in adults with episodic migraine
Flu Vaccine Benefits Extend to Fewer Pneumonia Admissions
Study suggests about 57 percent of hospitalizations for flu-related pneumonia might be prevented
β-Blockers May Up Risk of Surgical Complications for Some
Heightened risks of cardiovascular complications seen during non-cardiac surgeries
Add-On Sitagliptin Cuts Risk of Insulin Initiation in T2DM
Risk of insulin initiation lower for sitagliptin versus sulphonylurea as add-on to metformin
FDA Approves New Combo Therapy for Melanoma
Yervoy and Opdivo previously approved individually to treat melanoma
FDA Approves Keytruda for Advanced NSCLC
Approved for use with PD-L1 IHC 22C3 pharmDx test
September 2015 Briefing – Pharmacy
Here are what the editors at HealthDay consider to be the most important developments in Pharmacy for September 2015. This roundup includes the latest...
